Lombard Medical, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EVARF research report →
Companywww.lombardmedical.com
Lombard Medical, Inc. , a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees.
- CEO
- Kurt Lemvigh
- IPO
- 2014
- Employees
- 113
- HQ
- Didcot, GB
Price Chart
Valuation
- Market Cap
- $2.79K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.41
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 7.85%
- Op Margin
- -241.06%
- Net Margin
- -255.03%
- ROE
- -108.73%
- ROIC
- -45.19%
Growth & Income
- Revenue
- $12.17M · -19.49%
- Net Income
- $-31,035,000 · 17.91%
- EPS
- $-1.54 · 27.70%
- Op Income
- $-29,335,000
- FCF YoY
- 24.67%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.74
- Avg Volume
- 111.344
Get TickerSpark's AI analysis on EVARF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our EVARF Coverage
We haven't published any research on EVARF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EVARF Report →